IDiyas

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Dustin L McMinn

LinkedIn
USPTO Granted Patents = 31 


Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 131(Granted Patents)


Location History:

  • So. San Francisco, CA (US) (2004)
  • South San Francisco, CA (US) (2009)
  • Pacifica, CA (US) (2007 - 2024)

Company Filing History:

goldMedal14 out of 1,970 
 
Amgen Inc.
 patents
silverMedal7 out of 9 
 
Kezar Life Sciences
 patents
bronzeMedal5 out of 50 
 
Onyx Therapeutics, Inc.
 patents
4. 3 out of 9 
 
Genesoft Pharmaceuticals, Inc.
 patents
5. 1 out of 1,037 
 
Japan Tobacco Inc.
 patents
6. 1 out of 15,458 
 
University of California
 patents
7. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2004-2024

where 'Filed Patents' based on already Granted Patents

31 patents (USPTO):
1. 11976053 - Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof (2024-05-07),
2. 11891383 - Crystalline salts of peptide epoxyketone immunoproteasome inhibitor (2024-02-06),
3. 11498907 - Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof (2022-11-15),
4. 11479548 - Crystalline salts of peptide epoxyketone immunoproteasome inhibitor (2022-10-25),
5. 11339193 - CDP protein secretion inhibitors (2022-05-24),
6. 11078233 - Tripeptide epoxy ketone protease inhibitors (2021-08-03),
7. 10836756 - Crystalline salts of peptide epoxyketone immunoproteasome inhibitor (2020-11-17),
8. 10781192 - Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof (2020-09-22),
9. 10647744 - Tripeptide epoxy ketone protease inhibitors (2020-05-12),
10. RE47302 - Peptide epoxyketone immunoproteasome inhibitors (2019-03-18),
11. 9657057 - Dipeptide and tripeptide epoxy ketone protease inhibitors (2017-05-23),
12. 9593129 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer (2017-03-14),
13. 9434761 - Tripeptide epoxy ketone protease inhibitors (2016-09-06),
14. 9296736 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer (2016-03-29),
15. 8980903 - Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors (2015-03-17),

Title: The Innovative Journey of Dustin L McMinn

Introduction: Dustin L McMinn, a talented inventor based in South San Francisco, CA (US), has made significant contributions to the field of innovations with his creative mind and dedication to progress.

Latest Patents: Dustin L McMinn holds several patents in various technological fields, showcasing his versatility and expertise in innovation. His recent patents focus on cutting-edge solutions in the fields of biotechnology and renewable energy.

Career Highlights: With a background in engineering and a passion for problem-solving, Dustin L McMinn has had a remarkable career marked by groundbreaking inventions. His ability to think outside the box and his commitment to pushing boundaries have led to the development of revolutionary technologies.

Collaborations: Throughout his career, Dustin L McMinn has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His collaborative spirit and willingness to share knowledge have been instrumental in the success of his projects.

Conclusion: Dustin L McMinn's journey as an inventor is a testament to the power of innovation and perseverance. His dedication to creating a better future through his inventions serves as an inspiration to aspiring inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…